Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clément Viguier

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Infectious Diseases|April 15, 2026
Recent advances in flavivirus encephalitisClément Viguier, Jean-Michel Mansuy, Guillaume Martin-Blondel
Antimicrobial Agents and Chemotherapy|December 4, 2023
Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor taniborbactam against metallo-β-lactamasesChristophe Le Terrier, Clément Viguier, Patrice Nordmann, et al.
Journal of Clinical Microbiology|October 4, 2023
Rapid Aztreonam/Avibactam NP test for detection of aztreonam/avibactam susceptibility/resistance in EnterobacteralesClément Viguier, Maxime Bouvier, Mustafa Sadek, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 23, 2026
In vitro activity of β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with aztreonam against metallo-β-lactamase producing Escherichia coli clinical isolatesClément Viguier, Samanta Freire, Maxime Bouvier, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2024
Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor xeruborbactam in comparison with taniborbactam against metallo-β-lactamases produced in <i>Escherichia coli</i> and <i>Pseudomonas aeruginosa</i>Christophe Le Terrier, Samanta Freire, Clément Viguier, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 10, 2025
From neglected to notoriety: a review of Mpox clinical features, virology, epidemiology, treatment and prevention strategiesClément Viguier, Pierre Delobel, François-Xavier Lescure, et al.
Infectious Diseases Now|February 27, 2026
Combination of ertapenem and penicillin M or cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: multicenter case seriesLouis Bohard, Yohan N'Guyen, Pierre Danneels, et al.
Emergency Medicine Journal : EMJ|June 10, 2026
Prediction of bloodstream infection using triage variables in the emergency department: retrospective derivation and validation cohortFrederic Balen, Xavier Dubucs, Marion Graciet, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 18, 2022
A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcomeClément Viguier, Tristan de Kermel, Xavier Boumaza, et al.
Ecology|November 22, 2016
Early warning of critical transitions in biodiversity from compositional disorderC Patrick Doncaster, Vasthi Alonso Chávez, Clément Viguier, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Infectious Diseases|April 15, 2026
Recent advances in flavivirus encephalitisClément Viguier, Jean-Michel Mansuy, Guillaume Martin-Blondel
Antimicrobial Agents and Chemotherapy|December 4, 2023
Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor taniborbactam against metallo-β-lactamasesChristophe Le Terrier, Clément Viguier, Patrice Nordmann, et al.
Journal of Clinical Microbiology|October 4, 2023
Rapid Aztreonam/Avibactam NP test for detection of aztreonam/avibactam susceptibility/resistance in EnterobacteralesClément Viguier, Maxime Bouvier, Mustafa Sadek, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 23, 2026
In vitro activity of β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with aztreonam against metallo-β-lactamase producing Escherichia coli clinical isolatesClément Viguier, Samanta Freire, Maxime Bouvier, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2024
Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor xeruborbactam in comparison with taniborbactam against metallo-β-lactamases produced in <i>Escherichia coli</i> and <i>Pseudomonas aeruginosa</i>Christophe Le Terrier, Samanta Freire, Clément Viguier, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 10, 2025
From neglected to notoriety: a review of Mpox clinical features, virology, epidemiology, treatment and prevention strategiesClément Viguier, Pierre Delobel, François-Xavier Lescure, et al.
Infectious Diseases Now|February 27, 2026
Combination of ertapenem and penicillin M or cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: multicenter case seriesLouis Bohard, Yohan N'Guyen, Pierre Danneels, et al.
Emergency Medicine Journal : EMJ|June 10, 2026
Prediction of bloodstream infection using triage variables in the emergency department: retrospective derivation and validation cohortFrederic Balen, Xavier Dubucs, Marion Graciet, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 18, 2022
A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcomeClément Viguier, Tristan de Kermel, Xavier Boumaza, et al.
Ecology|November 22, 2016
Early warning of critical transitions in biodiversity from compositional disorderC Patrick Doncaster, Vasthi Alonso Chávez, Clément Viguier, et al.
Pageof 2